To include your compound in the COVID-19 Resource Center, submit it here.

FDA clears MabSpace's PD-L1 mAb for first-in-human trial

MabSpace Biosciences Co. Ltd. (Suzhou, China) said FDA approved an IND to begin

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE